Application of sebomics for the analysis of residual skin surface components to detect potential biomarkers of type-1 diabetes mellitus

Satyajit S Shetage, Matthew J Traynor, Marc B Brown, Thomas M Galliford, Robert P Chilcott

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)
53 Downloads (Pure)

Abstract

Metabolic imbalance in chronic diseases such as type-1 diabetes may lead to detectable perturbations in the molecular composition of residual skin surface components (RSSC). This study compared the accumulation rate and the composition of RSSC in type-1 diabetic patients with those in matched controls in order to identify potential biomarkers of the disease. Samples of RSSC were collected from the foreheads of type-1 diabetic (n = 55) and non-diabetic (n = 58) volunteers. Samples were subsequently analysed to identify individual components (sebomic analysis). There was no significant difference in the rate of accumulation of RSSC between type-1 diabetics and controls. In terms of molecular composition, 171 RSSC components were common to both groups, 27 were more common in non-diabetics and 18 were more common in type-1 diabetic patients. Statistically significant (P < 0.05) differences between diabetic and non-diabetic volunteers were observed in the recovered amounts of one diacylglyceride (m/z 594), six triacylglycerides (m/z 726-860) and six free fatty acids (m/z 271-345). These findings indicate that sebomic analysis can identify differences in the molecular composition of RSSC components between type-1 diabetic and non-diabetic individuals. Further work is required to determine the practical utility and identity of these potential biomarkers.

Original languageEnglish
Pages (from-to)8999
JournalScientific Reports
Volume7
Issue number1
DOIs
Publication statusPublished - 21 Aug 2017

Keywords

  • Journal Article

Fingerprint

Dive into the research topics of 'Application of sebomics for the analysis of residual skin surface components to detect potential biomarkers of type-1 diabetes mellitus'. Together they form a unique fingerprint.

Cite this